TrimmTrack
Sign in

Moderna (MRNA) valuation

Run six valuation models on Moderna with live data: DCF, Reverse DCF, Graham number, Monte Carlo, scenarios and sum-of-the-parts (NAV).

MRNA
MRNA

Moderna

MRNA · Healthcare

Current price

63,63 USD

You're trying every model for free, no account needed. Sign up to save your analyses →

Valuation

Market cap
$25.4B
PE (TTM | NTM | +1y)
— | -13.16 | -12.97
Price / Sales
11.40
EV / EBITDA
-9.26
Price / Book
3.75

Cash flow

FCF yield(0.75 / 63.63)
+1.18%
SBC-adjusted FCF yield
—
SBC impact
—

Margins & growth

Profit margin
-141.43%
Operating margin
-557.93%
Quarterly earnings (YoY)
—
Quarterly revenue (YoY)
—

Balance

Cash
$5.14B
Debt
$1.29B
Net position
$3.85B

Dividend

Dividend yield
—
Payout ratio
0%
Next payout
—

Price (1 year)

+127.07%
$79.76

Revenue

estimate
Q2 23: $344MQ2 23Q3 23: $1.83BQ4 23: $2.81BQ4 23Q1 24: $167MQ2 24: $241MQ2 24Q3 24: $1.86BQ2 25: $137MQ2 25Q3 25: $1BQ4 25: $676MQ4 25Q1 26: $389MQ2 26: $143MQ2 26Q3 26 · estimate: $872.91MQ3 26$2.81B

EBITDA

Q2 25: -$760MQ2 25Q3 25: -$135MQ3 25Q4 25: -$724MQ4 25Q1 26: -$1.26BQ1 26Q2 26: -$687MQ2 26$0

Net income

Q2 23: -$1.38BQ2 23Q3 23: -$3.63BQ4 23: $217MQ4 23Q1 24: -$1.18BQ2 24: -$1.28BQ2 24Q3 24: $13MQ2 25: -$825MQ2 25Q3 25: -$200MQ4 25: -$826MQ4 25Q1 26: -$1.34BQ2 26: -$782MQ2 26$217M

Free cash flow

Q1 24: -$1.19BQ1 24Q2 25: -$922MQ2 25Q3 25: -$880MQ3 25Q4 25: $891MQ4 25Q1 26: -$692MQ1 26Q2 26: -$563MQ2 26$891M

EPS

estimate
Q2 23: -3.62Q2 23Q3 23: -9.53Q4 23: 0.63Q4 23Q1 24: -3.07Q2 24: -3.33Q2 24Q3 24: 0.03Q2 25: -2.13Q2 25Q3 25: -0.51Q4 25: -2.11Q4 25Q1 26: -3.40Q2 26: -1.97Q2 26Q3 26 · estimate: -1.35Q3 260.63

Cash & debt

CashDebt
Q2 23 · Cash: $3.8BQ2 23Q3 23 · Cash: $2.93BQ4 23 · Cash: $2.91BQ4 23Q1 24 · Cash: $2.05BQ2 24 · Cash: $2.48BQ2 24Q3 24 · Cash: $1.64BQ2 25 · Cash: $1.28BQ2 25 · Debt: $741MQ2 25Q3 25 · Cash: $1.13BQ3 25 · Debt: $734MQ4 25 · Cash: $2.6BQ4 25 · Debt: $1.31BQ4 25Q1 26 · Cash: $1.91BQ1 26 · Debt: $1.3BQ2 26 · Cash: $1.72BQ2 26 · Debt: $1.29BQ2 26$3.8B

Return of capital

DividendsBuybacks
Q1 24 · Buybacks: $0Q1 24$1

Shares outstanding

Q2 23: 381MQ2 23Q3 23: 380.59MQ3 23: 381MQ4 23: 381.28MQ4 23: 382MQ4 23Q1 24: 383MQ2 24: 383.24MQ2 24: 384MQ3 24: 384.4MQ3 24Q3 24: 385MQ4 24: 384.82MQ1 25: 385.82MQ2 25: 386.74MQ2 25Q2 25: 389MQ3 25: 389.08MQ3 25: 390.58MQ4 25: 390.68MQ4 25Q4 25: 394MQ1 26: 394.94MQ1 26: 396.59MQ2 26: 396.79MQ2 26: 399MQ2 26399M

Stock-based compensation

Q1 24: $101MQ1 24Q2 25: $130MQ2 25Q3 25: $125MQ3 25Q4 25: $113MQ4 25Q1 26: $104MQ1 26Q2 26: $120MQ2 26$130M

Operating expenses

R&DSG&A
Q2 23 · R&D: $1.15BQ2 23 · SG&A: $332MQ2 23Q3 23 · R&D: $1.16BQ3 23 · SG&A: $442MQ4 23 · R&D: $1.41BQ4 23 · SG&A: $470MQ4 23Q1 24 · R&D: $1.06BQ1 24 · SG&A: $274MQ2 24 · R&D: $1.22BQ2 24 · SG&A: $268MQ2 24Q3 24 · R&D: $1.14BQ3 24 · SG&A: $281MQ2 25 · R&D: $700MQ2 25 · SG&A: $230MQ2 25Q3 25 · R&D: $801MQ3 25 · SG&A: $268MQ4 25 · R&D: $775MQ4 25 · SG&A: $308MQ4 25Q1 26 · R&D: $649MQ1 26 · SG&A: $173MQ2 26 · R&D: $651MQ2 26 · SG&A: $216MQ2 26$1.88B

Source: Yahoo Finance. Quarterly history grows automatically over time as new quarters are published.

Popular companies

AppleNvidiaTeslaMicrosoftAmazonAlphabet (Google)Meta PlatformsNetflixAMDPalantirBerkshire HathawayJPMorgan ChaseVisaMastercardWalt DisneyCoca-ColaPepsiCoMcDonald'sNikeStarbucksIntelBroadcomQualcommOracleSalesforceAdobePayPalUberAirbnbCoinbase